Gossamer Bio, Inc.（GOSS）内部人交易：高管与董事近期交易
过去 18 个月，共有 7 位内部人为 Gossamer Bio, Inc.（GOSS）报告了 13 笔 Form 4 交易（最近一笔 2026-01-05）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-01-05 | Christian Waage | EVP, Tech Ops and Admin | 买入 | 84,500 | $0 |
| 2026-01-05 | Giraudo Bryan | COO/CFO | 买入 | 115,750 | $0 |
| 2026-01-05 | Hasnain Faheem | President & CEO | 买入 | 280,000 | $0 |
| 2026-01-05 | Aranda Richard | Chief Medical Officer | 买入 | 93,750 | $0 |
| 2026-01-05 | Peterson Caryn | EVP, Regulatory Affairs | 买入 | 84,500 | $0 |
| 2026-01-05 | Smith Robert Paul JR | Chief Commercial Officer | 买入 | 93,750 | $0 |
| 2025-10-02 | Smith Robert Paul JR | Chief Commercial Officer | 买入 | 162,500 | $0 |
| 2025-10-02 | Giraudo Bryan | COO/CFO | 买入 | 181,250 | $0 |
| 2025-10-02 | Peterson Caryn | EVP, Regulatory Affairs | 买入 | 125,000 | $0 |
| 2025-10-02 | Aranda Richard | Chief Medical Officer | 买入 | 162,500 | $0 |
| 2025-10-02 | Hasnain Faheem | President & CEO | 买入 | 437,500 | $0 |
| 2025-10-02 | Christian Waage | EVP, Tech Ops and Admin | 买入 | 125,000 | $0 |
| 2025-08-20 | Milligan Sandra | 董事 | 买入 | 26,050 | $50,016 |
来源：SEC Form 4 申报文件 · 截至 2026-01-05